The American Academy of Neurology's Top Five Choosing Wisely recommendations
Authors:
- Annette M. Langer-GouldALAnnette M. Langer-Gould
- Wayne E. AndersonWAWayne E. Anderson
- Melissa J. ArmstrongMAMelissa J. Armstrong
- Adam B. CohenACAdam B. Cohen
- Matthew A. EccherMEMatthew A. Eccher
- Donald J. IversonDIDonald J. Iverson
- Sonja B. PotrebicSPSonja B. Potrebic
- Amanda BeckerABAmanda Becker
- Rod LarsonRLRod Larson
- Alicia GedanAGAlicia Gedan
- Thomas S.D. GetchiusTGThomas S.D. Getchius
- Gary S. GronsethGGGary S. Gronseth
- 10 September 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 81 (11) , 1004-1011
Abstract
Objective: To discuss the American Academy of Neurology (AAN)9s Top Five Recommendations in the Choosing Wisely campaign promoting high-value neurologic medicine and physician–patient communication. The AAN published its Top Five Recommendations in February 2013 in collaboration with the American Board of Internal Medicine Foundation and Consumer Reports. Methods: A Choosing Wisely Working Group of 10 AAN members was formed to oversee the process and craft the evidence-based recommendations. AAN members were solicited for recommendations, the recommendations were sent out for external review, and the Working Group members (article authors) used a modified Delphi process to select their Top Five Recommendations. Results and recommendations: The Working Group submitted 5 neurologic recommendations to the AAN Practice Committee and Board of Directors; all 5 were approved by both entities in September 2012. Recommendation 1: Don9t perform EEGs for headaches. Recommendation 2: Don9t perform imaging of the carotid arteries for simple syncope without other neurologic symptoms. Recommendation 3: Don9t use opioids or butalbital for treatment of migraine, except as a last resort. Recommendation 4: Don9t prescribe interferon-β or glatiramer acetate to patients with disability from progressive, nonrelapsing forms of multiple sclerosis. Recommendation 5: Don9t recommend carotid endarterectomy for asymptomatic carotid stenosis unless the complication rate is low (<3%).Keywords
This publication has 32 references indexed in Scilit:
- Rescue Therapy for Acute Migraine, Part 3: Opioids, NSAIDs, Steroids, and Post‐Discharge MedicationsHeadache: The Journal of Head and Face Pain, 2012
- Cost of Health Care Among Patients With Chronic and Episodic Migraine in Canada and the USA: Results From the International Burden of Migraine Study (IBMS)Headache: The Journal of Head and Face Pain, 2011
- Forecasting the Future of Cardiovascular Disease in the United StatesCirculation, 2011
- Guidelines for the Primary Prevention of StrokeStroke, 2011
- Stenting versus Endarterectomy for Treatment of Carotid-Artery StenosisNew England Journal of Medicine, 2010
- Low Risk of Ipsilateral Stroke in Patients With Asymptomatic Carotid Stenosis on Best Medical TreatmentStroke, 2010
- Guidelines for the diagnosis and management of syncope (version 2009): The Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC)European Heart Journal, 2009
- EFNS guideline on the drug treatment of migraine – revised report of an EFNS task forceEuropean Journal of Neurology, 2009
- Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double‐blind, placebo‐controlled trialAnnals of Neurology, 2007
- Multistate improvement in process and outcomes of carotid endarterectomyJournal of Vascular Surgery, 2004